alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
(1) 

AIRWORTHINESS 

DIRECTIVE

CIVIL AVIATION AUTHORITY 

CZECH REPUBLIC 

Airport Ruzyne, 160 08 Prague 6

tel: 420-2-33320922, fax: 420-2-20562270 

Number: CAA-AD-T-112/1999R1 

Supersedes CAA-AD-T-112/1999 

Date of issue: November 23, 1999

LET, a.s., Kunovice 

AEROTECHNIK CZ s.r.o., Kunovice 

L 13, L 13A, L 13AC, L 13SW, L 13SE, ++

SAILPLANE - TAIL-FUSELAGE ATTACHMENT FITTING - 

INSPECTION/REPLACEMENT

Applicability: Sailplane L 13, all models and serial numbers, certificated in any category. Powered sailplane 

L 13 SW Vivat, L 13 SL Vivat and L 13 SEH Vivat, all models and serial numbers, certificated in any category. 

Reason: To prevent destruction of tail-fuselage attachment fitting which can lead to loss of control of the 

sailplane. This destruction could be caused due to lower strength of the material used during production. 

Effective date: Upon receipt. 

Compliance : Action must be done prior to further flight in accordance with LET, a.s., Mandatory Bulletin No. 

L13/085a dated November 17, 1999 which becomes herewith part of this AD and may be obtained from: LET, 

a.s., 686 04 Kunovice 1177, CZECH REPUBLIC or in accordance with AEROTECHNIK CZ s.r.o. Mandatory 

Bulletin No. SW 13-048a, SEH 13-005a, SL 13-004a dated November 18, 1999, which becomes herewith part of 

this AD and may be obtained from: AEROTECHNIK CZ s.r.o., 686 04 Kunovice, CZECH REPUBLIC. 

Remarks: - Where applicable, the requirements of this AD must be integrated into the Aircraft Logbook(s).

 - Address inquiries concerning this AD to: Civil Aviation Authority, Airworthiness Division,

 Ruzyne Airport, 160 08 Prague 6, Czech Republic, tel: 420 2 33320922, fax: 420 2 20562270. 

 Ing. Pavel MATOUŠEK 

 Director of Airworthiness Division

 CAA CZ 

 CAA-AD-T-112/1999R1

 1/1
Exhibit 10.42

      

      

      FIRST AMENDMENT TO OPTION AND LICENSE AGREEMENT

      

      

      This First Amendment to Option and License Agreement (the “Amendment”), effective as of November 19, 2020 (the “First Amendment Effective Date”) by and between GigaGen, Inc., a Delaware
          corporation having a place of business at 1 Tower Place, Suite 750, South San Francisco, CA 94080 (“GigaGen”) and Kineta, Inc., a Washington corporation having a place of business at 219 Terry Avenue North, Suite 300, Seattle, WA 98109 (“Kineta”), amends that certain Option and License Agreement, dated August 10, 2020 by and between GigaGen and Kineta (the “Agreement”).  Each of GigaGen and Kineta shall be referred to herein
          individually as a “Party” and collectively as the “Parties”.  Capitalized terms not defined herein shall have the
        same meanings as set forth in the Agreement.

      

      

      NOW, THEREFORE, in consideration of the mutual promises set forth herein, the Parties hereby agree as follows:

      

      

      1.

      Section 1.52 of the Agreement is hereby amended by deleting in its entirety and replacing it with the following:

      

      

      “Option Term” means the period commencing on the Effective Date and ending on December 31, 2020.

      

      

      2.

      Except as set forth herein, all other terms and conditions of the Agreement shall remain in full force and effect.

      

      

      3.

      This Amendment may be signed in counterparts, each of which shall be an original, with the same effect as if the signatures were upon the same instrument.

      
        
          


      

      

      

      IN WITNESS WHEREOF, duly authorized representatives of the Parties have duly executed this Amendment as of the First Amendment Effective Date.

      

      

      	
              GIGAGEN, INC.

            	 	
              KINETA, INC.

            
	 	 	 	 	 
	
              Signature:

            	
              /s/ David Johnson

            	 	
              Signature:

            	
              /s/ Craig Philips

            
	 	

            	 	 	

            
	
              Name:

            	
              David Johnson

            	 	
              Name:

            	
              Craig Philips

            
	 	

            	 	 	

            
	
              Title:

            	
              Chief Executive Officer

            	 	
              Title:

            	
              President

            
	 	

            	 	 	

            
	
              Date:

            	
              11/19/2020

            	 	
              Date:

            	
              11/19/2020
#### Gloria MILLER, Appellant, v. Genevieve S. IRONS, Appellee.

No. O-494.

District Court of Appeal of Florida, First District.

Nov. 11, 1971.

PER CURIAM.

Affirmed.
gas

If**Al~egheny** Valley Joint Sewage Author i ty
- Wastewater Treatmen t Plant desires to accept oil and gas**exp~oration** and/or production wastewater after signing this certification, Allegheny Valley Joint Sewage Authority -Wastewater Treatmen t Plant w i ll, prior to acceptance : Notify EPA Region III and PADEP of its intent, take all actions necessary to comply with the Clean water Act (CWA) and receive all necessary approvals from EPA and PADEP.

As a managing true and correct. under the civil and provide for the imprisonment. company official, I certify that this statement is I am aware that violations of CWA are punishable criminal provisions of Section 309 of the CWA, which assessment of penalties , injunctive relief and

B y

# ~~a.**v~ cha~** **l: hiave** **tt a**  Plant M anag r

October 3, 2011 Date
#### HOWARD AVENUE REALTY CORPORATION v. H. P. McINTOSH, IV.

No. 61386.

Supreme Court of Louisiana.

Feb. 17, 1978.

In re: Henry P. McIntosh, IV, applying for certiorari, or writ of review, to the Court of Appeal, Fourth Circuit. Parish of Orleans. 352 So.2d 348.

Writ denied.

SUMMERS, J., would grant the writ.
#### Richard Lee TURNER, Appellant, v. STATE of Florida, Appellee.

No. N-242.

District Court of Appeal of Florida, First District.

June 3, 1971.

Louis O. Frost, Jr., Public Defender, and Gerald Sohn, Asst. Public Defender, for appellant.

Robert L. Shevin, Atty. Gen., and William W. Herring, Asst. Atty. Gen., for ap-pellee.

PER CURIAM.

The record and briefs have been carefully considered. The Appellant has failed to demonstrate reversible error. There*686fore, the judgment and sentence appealed from is

Affirmed.

WIGGINTON, Acting C. J., RAWLS, J., and MELVIN, WOODROW M., Associate Judge, concur.
#### GINSBERG v. OVERSTREET.

No. 38478.

Supreme Court of Florida.

June 1969.

Appeals, dismissed without opinion.
**Exhibit 23**

 

**Consent of Independent Registered Public Accounting Firm**

 

We consent to the incorporation by reference in the Registration Statements on Form S-8 of Material Sciences Corporation (No.’s 33-00067, 33-40610, 33-41310,33-57648, 33-81064, 333-15679, 333-15677, 333-33885, 333-33897 and 333-88387) of our reports dated July 7, 2005, relating to the consolidated financial statements and financial statement schedule of Material Sciences Corporation andmanagement’s report on the effectiveness of internal control over financial reporting (which audit report expresses an adverse opinion on the operating effectiveness of internal control over financial reporting as of February 28, 2005 based oncriteria established in Financial Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission) appearing in this Annual Report on Form 10-K of Material Sciences Corporation for the year endedFebruary 28, 2005. 

 

Deloitte & Touche LLP 

 

Chicago, Illinois 

July 8, 2005
EXHIBIT 23

            CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

        We have  issued  our  report  dated  March 28,  2007,  accompanying  the
consolidated  financial  statements  included in the Annual  Report of Berkshire
Bancorp Inc. and subsidiaries on Form 10-K for the year ended December 31, 2006.
We hereby  consent  to the  incorporation  by  reference  of said  report in the
Registration  Statement  of  Berkshire  Bancorp  Inc.  on Forms  S-8  (File  No.
333-41708,  effective July 19, 2000 and File No. 333-22287,  effective  February
25, 1997).


/s/ GRANT THORNTON LLP

New York, New York
March 28, 2007
i De Sng te Ye ut Sn, a A: cist

\/)

Als

_ State & OA ccethaa —, enumerated by me, 74a

DESCRIPTION,
we OF EVERY PERSON WHO DIED .
the Year ending 191 June, 1080, whose

fen Edn We Pam

==. 7

pg bee

PROFESSION, DISEASE, OR
OCCUPATION, OR CAUSE OF

ae? e
enataleares D B\5 | ~

Historic census records are maintained and released by
the National Archives and Records Administration,
not the U.S. Census Bureau.

; . , Visit http://www.archives.gov for more information about publicly
available records e the one shown here.

U\F |

r
’ a a
. : ee ae

”
[se
SC
Me
se
4

so
x | se ___

Note

re Bam le i ha
ee ee

Geet fe te

fA 4 Fleer = on LD)

po Atel rary

ese, Mee tlorie ei zc se Tae

SE PAIS SY Oe ee
kee BS eee eee i ee oe ee ee ee 22 Oe ee ee Mitre A ee eee ee CE ee, | |
\ it ? ’

i ee ee
Order entered December 6, 2018

In The

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-18-01041-CV

PINGHUA LEI, JIE ZHU, AND CHIUNG YING “JOANN” CHEN, Appellants

V.

NATURAL POLYMER INTERNATIONAL CORPORATION AND NPIC SHANGHAI 

CO., LTD., Appellees

On Appeal from the 199th Judicial District Court

Collin County, Texas

Trial Court Cause No. 199-01725-2018

ORDER

Before the Court is Bill Pedersen, III’s December 4, 2018 motion to withdraw as counsel 

for appellant Pinghua Lei. We GRANT the motion and DIRECT the Clerk of the Court to 

remove Mr. Pedersen as counsel for Mr. Lei. All future communication with Mr. Lei shall be 

directed to:

Pinghua Lei

neillei049@yahoo.com

11126 Still Hollow Dr.

Frisco, Texas 75035

(972) 750-0834.

On our own motion, we EXTEND the deadline for filing appellants’ reply brief to 

January 3, 2019.

/s/ DAVID EVANS 

JUSTICE
#### Martha A. FINLEY, a/k/a Mrs. John T. Finley, Appellant, v. William Oliver KUHN, Appellee.

No. 70-825.

District Court of Appeal of Florida, Third District.

Aug. 19, 1970.

PER CURIAM.

Appeal dismissed.
Exhibit 32.1





CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 906


OF THE SARBANES-OXLEY ACT OF 2002





I, William J. Gervais, Chief Executive Officer of Qualstar Corporation (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:





(1) the Annual Report on Form 10-K of the Company for the fiscal year ended June 30, 2011 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 780(d)); and





(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.





Dated: August 31, 2011





/s/WILLIAM J. GERVAIS


William J. Gervais,


Principal Executive Officer
[Federal Register Volume 83, Number 145 (Friday, July 27, 2018)]
[Notices]
[Page 35630]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-16081]


-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission


Combined Notice of Filings

    Take notice that the Commission has received the following Natural 
Gas Pipeline Rate and Refund Report filings:

Filings Instituting Proceedings

    Docket Numbers: RP18-980-000.
    Applicants: Panther Interstate Pipeline Energy, LLC.
    Description: Tariff Cancellation: PIPE Resubmission of Tariff 
Cancellation Filing to be effective 7/17/2018.
    Filed Date: 7/17/18.
    Accession Number: 20180717-5074.
    Comments Due: 5 p.m. ET 7/30/18.

    Docket Numbers: RP18-982-000.
    Applicants: Eastern Shore Natural Gas Company.
    Description: Sec.  4(d) Rate Filing: Negotiated Rate and Non-
Conforming Agreements to be effective 7/20/2018.
    Filed Date: 7/18/18.
    Accession Number: 20180718-5088.
    Comments Due: 5 p.m. ET 7/30/18.

    Docket Numbers: RP18-983-000.
    Applicants: Texas Eastern Transmission, LP.
    Description: Sec.  4(d) Rate Filing: Negotiated Rate--Exelon 
8950525 eff 11-01-2018 to be effective 11/1/2018.
    Filed Date: 7/18/18.
    Accession Number: 20180718-5103.
    Comments Due: 5 p.m. ET 7/30/18.

    Docket Numbers: RP18-984-000.
    Applicants: Equitrans, L.P.
    Description: Sec.  4(d) Rate Filing: Equitrans' Clean Up Filing--
July 2018 to be effective 8/18/2018.
    Filed Date: 7/18/18.
    Accession Number: 20180718-5115.
    Comments Due: 5 p.m. ET 7/30/18.

    The filings are accessible in the Commission's eLibrary system by 
clicking on the links or querying the docket number.
    Any person desiring to intervene or protest in any of the above 
proceedings must file in accordance with Rules 211 and 214 of the 
Commission's Regulations (18 CFR 385.211 and 385.214) on or before 5:00 
p.m. Eastern time on the specified comment date. Protests may be 
considered, but intervention is necessary to become a party to the 
proceeding.
    eFiling is encouraged. More detailed information relating to filing 
requirements, interventions, protests, service, and qualifying 
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call (866) 208-3676 
(toll free). For TTY, call (202) 502-8659.

    Dated: July 19, 2018.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2018-16081 Filed 7-26-18; 8:45 am]
 BILLING CODE 6717-01-P
IN THE DISTRICT COURT OF APPEAL OF THE STATE OF FLORIDA

FIFTH DISTRICT

NOT FINAL UNTIL TIME EXPIRES TO

FILE MOTION FOR REHEARING AND

DISPOSITION THEREOF IF FILED

BILLY RAY HARRIS, JR.

,

Appellant

,

v. Case No. 5D 17

- 3419

STATE OF FLORIDA

,

Appellee

.

________________________________/

Opinion filed July 20, 2018

Appeal from the Circuit Court for Volusia County

, Matthew M. Foxman , Judge.

James S. Purdy, Public Defender, and Kathryn Rolli s on Radtke, Assistant Public Defender, Daytona Beach, for Appellant.

Pamela Jo Bondi, Attorney General,
Tallahassee, and Pamela J. Koller, Assistant Attorney General, Daytona Beach, for Appellee.

PER CURIAM

.

We affirm, without further discussion, the judgments and sentences imposed by

the trial court following Appellant’s open plea in two cases below. However, because

there is a scrivener’s error in the order revoking probation entered in Case No. 20 15

-2 303740

- CFDB , we remand for the tr ial court to enter an amended order to accurately

reflect the conditions of probation that Appellant admitted to violating in that case.

AFFIRMED; REMANDED to correct scrivener’s error.

COHEN, C.J.

, EVANDER and LAMBERT , JJ., concur.
sa

alg ag

7p

TT 7=bs|

el

mn the

bis Nom 18, 1488 ana 0 are

‘Inhabitants::n,

ZA.

umerated by mi
i

crm

e 1

1

em

Visit http://www.archives.gov for more information about publicly available records like the one shown here.

SCHEDULE I.
##### 



EXHIBIT 5

(PRICEWATERHOUSE COOPERS LOGO)

CONSENT OF INDEPENDENT ACCOUNTANTS

We hereby consent to the incorporation in the Registration Statements on Form
F-9/F-3 (File Nos. 333-6756 and 333-6756-1) and Form F-3 (File No. 333-14148)
of Barrick Gold Corporation of our reports dated February 5, 2003 relating to
the consolidated financial statements, which appears in the Annual Report to
Shareholders, which is incorporated in this Annual Report on Form 40-F. We
also consent to the incorporation by reference of our reports dated February 5,
2003, which appears in this Form 40-F.



/s/ PricewaterhouseCoopers LLP

PricewaterhouseCoopers LLP
Toronto, Ontario
May 14, 2003

PricewaterhouseCoopers refers to the Canadian firm of PricewaterhouseCoopers LLP and the other member firms of PricewaterhouseCoopers International Limited, each of which is a separate and independent legal entity.
6(&7,21±'HVLJQ6SHFLILFDWLRQV

'HVLJQ6SHFLILFDWLRQV

7<3(2).,/1  ,52125(3(//(7,=,1*

%851(5&$3$&,7<

38/9(5,=('&2$/ 00%78+5

12)8(/2,/  00%78+5

1$785$/*$6  00%78+5RSHUDWLQJ00%78+5PD[

 

)8(/6

12)8(/2,/  86*3+$736,*

  %78*$/

$720,=,1*$,5  6&)0$7LQ:&

1$785$/*$6  6&)02SHUDWLQJ

  2SHUDWLQJ'3DFURVVEXUQHU36,*

  %786&)/+9

 

675$,*+76:,5/$,5 6&)0DWLQFKHV:&

3,/27

 1$785$/*$6  6&)02SHUDWLQJ

 %78VFI/+9

     SVLJPD[DFURVVSLORW

 

 3,/27$,5   6&)0'U\$LU2SHUDWLQJ

     SVLJPD[DFURVVSLORW

     6&)03XUJLQJ'U\$LU
EXHIBIT 99.1



Below each General Partner's name is a list of the limited  partnerships,  other
than the  Registrant,  for which the General Partner serves as a general partner
and the companies for which the General  Partner serves as a director.  The list
includes only those  limited  partnerships  and companies  which have a class of
securities  registered  pursuant to Section 12(g) of the Securities Exchange Act
of 1934 or are subject to the requirements of Section 15(d) of the Act.


Gregory J. Nooney, Jr.

  Limited Partnerships:

   Nooney Real Property Investors-Two, L.P.        Nooney Income Fund Ltd., L.P.
   Nooney Real Property Investors-Four, L.P.



   Directorships:

   Nooney Realty Trust, Inc.


John J. Nooney

  Limited Partnerships:

   Nooney Real Property Investors-Two, L.P.        Nooney Income Fund Ltd., L.P.
   Nooney Real Property Investors-Four, L.P.

PAN, Inc.

  Limited Partnerships:

   Nooney Real Property Investors-Two, L.P.        Nooney Income Fund Ltd., L.P.
   Nooney Real Property Investors-Four, L.P.

                                      -21-
II 

113TH CONGRESS 

1ST SESSION S. 1128 

To clarify the orphan drug exception to the annual fee on branded prescription 

pharmaceutical manufacturers and importers. 

IN THE SENATE OF THE UNITED STATES 

JUNE 11, 2013 

Mr. TOOMEY (for himself, Mr. CASEY, and Mr. CRAPO) introduced the 

following bill; which was read twice and referred to the Committee on Finance 

A BILL 

To clarify the orphan drug exception to the annual fee on 

branded prescription pharmaceutical manufacturers and 

importers. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Preserving Access to 

5 Orphan Drugs Act of 2013’’. 


sroberts on DSK5SPTVN1PROD with BILLS
2 

•S 1128 IS

1 SEC. 2. CLARIFICATION OF ORPHAN DRUG EXCEPTION TO 

2 ANNUAL FEE ON BRANDED PRESCRIPTION 

3 PHARMACEUTICAL MANUFACTURERS AND 

4 IMPORTERS. 

5 (a) IN GENERAL.—Paragraph (3) of section 9008(e) 

6 of the Patient Protection and Affordable Care Act (26 

7 U.S.C. 4001 note prec.; Public Law 111–148) is amended 

8 to read as follows: 

9 ‘‘(3) EXCLUSION OF ORPHAN DRUG SALES.— 

10 ‘‘(A) IN GENERAL.—The term ‘branded 

11 prescription drug sales’ shall not include sales 

12 of any drug or biological product— 

13 ‘‘(i) with respect to which a credit was 

14 allowed for any taxable year under section 

15 45C of the Internal Revenue Code of 1986; 

16 or 

17 ‘‘(ii) which is approved or licensed by 

18 the Food and Drug Administration for 

19 marketing solely for one or more rare dis20 eases or conditions. 

21 ‘‘(B) LIMITATION.—Subparagraph (A) 

22 shall not apply with respect to any drug or bio23 logical product after the date on which the drug 

24 or biological product is approved or licensed by 

25 the Food and Drug Administration for marVerDate Mar 15 2010 19:59 Jun 14, 2013 Jkt 029200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\S1128.IS S1128

sroberts on DSK5SPTVN1PROD with BILLS
3 

•S 1128 IS

1 keting for any indication other than the treat2 ment of a rare disease or condition. 

3 ‘‘(C) RARE DISEASE OR CONDITION.—In 

4 this paragraph, the term ‘rare disease or condi5 tion’ has the meaning given such term under 

6 section 45C(d)(1) of the Internal Revenue Code 

7 of 1986, except that in the case of any drug or 

8 biological product that has not been designated 

9 under section 526 of the Federal Food, Drug 

10 and Cosmetic Act for a particular indication, 

11 determinations under such section 45C(d)(1) 

12 shall be made on the basis of the facts and cir13 cumstances as of the date such drug or biologi14 cal product is approved or licensed by the Food 

15 and Drug Administration for marketing for the 

16 treatment of such disease or condition.’’. 

17 (b) EFFECTIVE DATE.—The amendment made by 

18 this section shall take effect as if included in section 9008 

19 of the Patient Protection and Affordable Care Act (26 

20 U.S.C. 4001 note prec.; Public Law 111–148). 

Æ 


sroberts on DSK5SPTVN1PROD with BILLS
262 La. 1072

#### NATIONAL FOOD STORES OF LOUISIANA, INC. v. Hon. Earle CEFALU, Mayor, Town of Amite, Louisiana, et al.

No. 52679.

Supreme Court of Louisiana.

Sept. 18, 1972.

In re: Hon. Earle Cefalu, Mayor, Town of Amite, Louisiana, et al. applying for certiorari, or writ of review, to the Court of Appeal, First Circuit, the Parish of Tangipahoa, 264 So.2d 289.

It is ordered that the writ of review issue ; that the Court of Appeal send up the record in duplicate of the case; and that counsel for plaintiff and defendant be notified.

Granted as a matter of right.
#### Clyde BAKER, Appellant, v. Leslie BEST, Appellee.

No. M-285.

District Court of Appeal of Florida, First District.

Sept. 24, 1970.

George A. Stelogeannis, of Greene, Greene, Kennedy & Stockton, Jacksonville, for appellant.

Boyd, Jenerette, Leemis & Staas, Jacksonville, for appellee.

PER CURIAM.

This cause having been orally argued before the court, the briefs and record on appeal having been read and given full consideration, and appellant having failed to demonstrate reversible error, the judgment of the lower court hereby appealed is affirmed. On the issue of damages, see Freeman v. Bandlow, (Fla.App.1962), 143 So.2d 547; Shaw v. Puleo, (Fla.1964) 159 So.2d 641. As to the applicability of the collateral source rule to the facts of this case, see McElwain v. Capotosto, (1954) 332 Mass. 1, 122 N.E.2d 901; Perry v. Public Service Coordinated Transport, (1948) 136 N.J.L. 398, 56 A.2d 617.

JOHNSON, C. J., and WIGGINTON and RAWLS, JJ., concur.
TX

CA

MT

AZ

MI

ID

NV

NM

CO

IL

OR

KS

WY

UT

FL

NE

SD

IA

WI

MN

OK

ND

WA

AL

LA

MO

GA

AR

NY

NC

PA

IN

MS

VA

KY

TN

OH

SC

ME

WV

VT

AK

NH

CT

NJ

MD

MA

DE

RI

Atlanta

Chicago

Denver

Los Angeles (includes Alaska and Hawaii)

New York (includes Puerto Rico)

Philadelphia

HI PR

0 200 mi

0 500 mi

0 100 mi 0 50 mi

^

^

^

^

^

^

LOS

ANGELES

DENVER

CHICAGO

ATLANTA

NEW YORK

CITY

CO

PHILADELPHIA

PA

REGIONS

AK Census Bureau Regional Office Boundaries

New structure as of January 2013